Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

All news

Show

From To
Sleep Abnormalities Do Not Reverse After Discontinuing Efavirenz

For patients with HIV receiving efavirenz-based therapy, sleep and neuropsychological abnormalities do not readily reverse after discontinuation of treatment, according to results published in HIV Clinical Trials.

Published
14 January 2019
From
Infectious Disease Advisor
Co-infection with HIV and HCV does not increase the risk of end-stage liver disease or liver cancer

People with HIV and hepatitis C are no longer at higher risk of end-stage liver disease than people with hepatitis C alone, and the trend is probably

Published
14 January 2019
By
Keith Alcorn
BASHH, BHIVA, HIVPA and NHIVNA statement on management of antiretroviral supplies in preparation for a no-deal Brexit Scenario

Clinicians do not need to issue longer, or earlier than usual, prescriptions and patients should be reassured that there is no need for concern about the supply of their medication and therefore no need to stockpile.

Published
11 January 2019
From
British HIV Association
NHS hope to double capacity of PrEP trial after huge demand for HIV prevention drug

Deborah Gold, Chief Executive of NAT (National AIDS Trust), said: “Having been pushing for increased access to PrEP for so long, we are pleased that NHS England has listened to us and agreed to fund more spaces for PrEP patients on the Impact trial. It has been completely unacceptable to see people in need of PrEP being turned away from clinics."

Published
11 January 2019
From
National AIDS Trust
Delving into community health and HIV in Brazil

Michael Touchton’s groundbreaking study, “Community Health Governance and HIV in Brazil,” is the first time there has been a large, comprehensive scholarly analysis of the effects of participatory democratic institutions and social policies on public health and how this can affect conditions and the capacity to deliver health services.

Published
11 January 2019
From
University of Miami
Reported cases of HIV in China are rising rapidly

That is mainly because getting tested is so much easier, and less intimidating

Published
11 January 2019
From
The Economist
Facing Legal Action, Insurer Now Will Cover People Taking Truvada, an H.I.V.-Prevention Drug

Regulators had accused Mutual of Omaha of denying policies to applicants, mostly gay men, who took medication to protect against the infection.

Published
11 January 2019
From
New York Times
DFID needs to keep pushing on AIDS, says HIV-positive MP

The United Kingdom’s aid department must put more resources into fighting HIV/AIDS or risk seeing global progress backslide, according to politician Lloyd Russell-Moyle, who stood up in the House of Commons and revealed he was HIV positive late last year.

Published
11 January 2019
From
Devex
Micro-level mapping in Zimbabwe identifies key HIV hotspots

A detailed geographic analysis of Zimbabwe's HIV epidemic indicates the greatest concentrations of people living with HIV who lack treatment are in the country’s main cities and urban settlements.

Published
11 January 2019
From
Avert
HIV Viral Load and Transmissibility of HIV Infection: Undetectable Equals Untransmittable

Viewpoint by Dr. Anthony Fauci and colleagues.

Published
11 January 2019
From
JAMA

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.